RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Quarter Return
-22.05%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$120M
AUM Growth
+$120M
Cap. Flow
+$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 91.9%
2 Communication Services 8.05%
3 Technology 0.05%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$59.9M 49.9%
3,766,666
TVRD
2
Tvardi Therapeutics, Inc. Common Stock
TVRD
$277M
$35.6M 29.66%
2,799,058
MRSN icon
3
Mersana Therapeutics
MRSN
$35M
$14.8M 12.35%
796,458
LVO icon
4
LiveOne
LVO
$58.1M
$9.66M 8.05%
3,724,138
SENS icon
5
Senseonics Holdings
SENS
$369M
$62K 0.05%
159,601